التفاصيل البيبلوغرافية
| العنوان: |
Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial |
| المؤلفون: |
Marconi, Vincent C, Ramanan, Athimalaipet V, de Bono, Stephanie, Kartman, Cynthia E, Krishnan, Venkatesh, Liao, Ran, Piruzeli, Maria Lucia B, Goldman, Jason D, Alatorre-Alexander, Jorge, de Cassia Pellegrini, Rita, Estrada, Vicente, Som, Mousumi, Cardoso, Anabela, Chakladar, Sujatro, Crowe, Brenda, Reis, Paulo, Zhang, Xin, Adams, David H, Ely, E Wesley, Ahn, Mi-Young, Akasbi, Miriam, Altclas, Javier David, Ariel, Federico, Ariza, Horacio Alberto, Atkar, Chandrasekhar, Bertetti, Anselmo, Bhattacharya, Meenakshi, Briones, Maria Luisa, Budhraja, Akshay, Burza, Aaliya, Camacho Ortiz, Adrian, Caricchio, Roberto, Casas, Marcelo, Cevoli Recio, Valeria, Choi, Won Suk, Cohen, Emilia, Comulada-Rivera, Angel, Cook, Paul, Cornejo Juarez, Dora Patricia, Daniel, Carnevali, Degrecci Relvas, Luiz Fernando, Dominguez Cherit, Jose Guillermo, Ellerin, Todd, Enikeev, Dmitry, Erico Tanni Minamoto, Suzana, Fiss, Elie, Furuichi, Motohiko, Giovanni Luz, Kleber |
| المساهمون: |
Eli Lilly and Company, Incyte, Intel Corporation |
| المصدر: |
The Lancet Respiratory Medicine ; volume 9, issue 12, page 1407-1418 ; ISSN 2213-2600 |
| بيانات النشر: |
Elsevier BV |
| سنة النشر: |
2021 |
| المجموعة: |
ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| نوع الوثيقة: |
article in journal/newspaper |
| اللغة: |
English |
| DOI: |
10.1016/s2213-2600(21)00331-3 |
| الإتاحة: |
https://doi.org/10.1016/s2213-2600Test(21)00331-3
https://api.elsevier.com/content/article/PII:S2213260021003313?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S2213260021003313?httpAccept=text/plainTest |
| حقوق: |
https://www.elsevier.com/tdm/userlicense/1.0Test/ |
| رقم الانضمام: |
edsbas.5223DBFA |
| قاعدة البيانات: |
BASE |
